排序方式: 共有14条查询结果,搜索用时 15 毫秒
1.
近年来我军新兵学历不断提高,据报道2010年海军新兵大专以上学历占24.9%,北京市2010年征集的新兵中大专以上学历占35.8%。2011年5月国务院原则通过《中华人民共和国兵役法修正案(草案)》,"草案"强调吸引高文化素质青年入伍。随着多项措施的实行, 相似文献
2.
Background Contrast induced nephropathy(CIN) is associated with increased mortality. serum creatinine(sCr) and serum cystatin C(sCys C) have diagnostic value for CIN in patients taking coronary angiography(CAG). However, whether sCys C is superior to sCr is still controversial. Methods All 280 patients undergoing PCI from July 2015 to July 2017 in Shunde Hospital, Southern Medical University were enrolled in this prospective study. The plasma levels of sCr and sCys C were measured in fasting blood samples in the morning before angiography and at 48 hours and 72 hours after the procedure. Receiver operating characteristic curve(ROC)analysis was performed for sCr and sCys C 48 hours after procedure. Results According to sCys C criteria, CIN occurred in 85 patients(30.4%) after contrast exposure, while, CIN occurred in 22 patients(7.9%). ROC curve analysis found that AUC for sCr and sCys C was 0.741(P0.05, 95% CI = 0.613-0.869) and 0.720(P0.05, 95%CI = 0.590-0.851), respectively without significantly different(P=0.412). Conclusion The sCys C is not superior to s Cr for predicting CIN in angiography patients. 相似文献
3.
HBeAg阴性慢性乙肝患者血清前S1抗原检测的临床价值 总被引:5,自引:0,他引:5
目的:探讨HBeAg阴性慢性乙型肝炎患者血清前S1抗原检测的意义及临床应用价值.方法:检测225例HBeAg阴性慢性乙型肝炎患者血清前S1抗原,同时检测HBV-DNA、ALT、AST及γ-GT.结果:225例HBeAg阴性样本中前S1抗原阳性133例(59.11%),HBV-DNA阳性124例(55.11%),二者高度一致(Kappa=0.75,P<0.05);前S1抗原阳性组42例ALT升高(35.90%),48例AST升高(41.03%),51例γ一GT升高(43.59%);前S1抗原阴性组7例ALT升高(6.48%),9例AST升高(8.33%),13例γ-GT升高(12.04%),两组比较,差异均有显著性(P<0.05).结论:对HBeAg阴性的慢性乙型肝炎患者在作乙肝标志物检测的同时检测前S1抗原能敏感的反映其体内乙肝病毒复制情况及评估其传染性.前Sl抗原与AIJrr、AST及γ-GT相关,可作为HBeAg阴性慢性乙型肝炎患者肝细胞损害的一项指标,对乙肝的诊断、监测疗效与预后判断具有重要的临床价值. 相似文献
4.
5.
我院口腔科有四台进口牙科综合治疗机。其中西德卡获型一台、捷克519MH型两台、捷克654BH型一台,使用时间都十余年了。由于长期磨损,部分零件老化等,机器的故障显著增加。此类进口机零配件现在国内难买,按常规修理,不少进口机价钱都比较贵,淘汰了可惜,但又不好用,再买新机器经费比较紧张, 相似文献
6.
7.
目的 探讨碱基切除修复交叉互补基因(XRCC1)和脱嘌呤/脱嘧啶核酸内切酶(APE1)单核苷酸多态性与非小细胞肺癌(NSCLC)放化疗疗效的关系。方法 230例晚期不能手术治疗的NSCLC患者为试验对象。取患者治疗前抗凝外周血,提取有核细胞DNA,采用Taqman探针基因分型技术检测XRCC1 Arg194Trp,XRCC1 Arg399Gln 和APE1 Asn148Glu单核苷酸多态性。结果 在单纯化疗或放疗的患者中,治疗敏感和不敏感的患者XRCC1、 APE1基因型差异无统计学意义。在放化疗联合治疗组中,XRCC1基因型与疗效无显著性相关,但APE1(Asn148Glu,T/G)位点与疗效有一定的相关性。在Ⅲa和 Ⅲb无胸膜浸润组,携带有G/G或G/T基因型的患者对放化疗不敏感的可能性是携带有T/T基因型患者3.25倍(P = 0.043)。结论 APE1 Asn148Glu位点可能是一个依赖于临床分期的放化疗疗效预测的指标,APE1野生纯合型148 T/T(Asn148Asn)可能是Ⅲa期和Ⅲb期无胸膜浸润NSCLC放化疗敏感的标志。 相似文献
8.
10.